Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J; UK Flexible Sigmoidoscopy Trial Investigators..

Lancet. 2010 May 8;375(9726):1624-33. doi: 10.1016/S0140-6736(10)60551-X.

2.

NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening.

Steinwachs D, Allen JD, Barlow WE, Duncan RP, Egede LE, Friedman LS, Keating NL, Kim P, Lave JR, LaVeist TA, Ness RB, Optican RJ, Virnig BA.

NIH Consens State Sci Statements. 2010 Feb 4;27(1):1-31. Review.

3.

Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected.

Kafadar K, Prorok PC.

Stat Med. 2009 Jul 20;28(16):2116-46. doi: 10.1002/sim.3601.

PMID:
19424959
4.

Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.

Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM.

Ann Intern Med. 2008 Nov 4;149(9):659-69.

5.

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70.

6.
7.

Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study.

Gupta AK, Melton LJ 3rd, Petersen GM, Timmons LJ, Vege SS, Harmsen WS, Diehl NN, Zinsmeister AR, Ahlquist DA.

Clin Gastroenterol Hepatol. 2005 Feb;3(2):150-8.

PMID:
15704049
8.

Screening for colorectal cancer: recommendation and rationale.

U.S. Preventive Services Task Force..

Ann Intern Med. 2002 Jul 16;137(2):129-31.

PMID:
12118971
9.

The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM.

N Engl J Med. 2000 Nov 30;343(22):1603-7.

10.

Cost-effectiveness of screening for colorectal cancer in the general population.

Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

JAMA. 2000 Oct 18;284(15):1954-61.

PMID:
11035892
11.

Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F, Inadomi JM.

Ann Intern Med. 2000 Oct 17;133(8):573-84.

PMID:
11033584
12.

Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G.

N Engl J Med. 2000 Jul 20;343(3):162-8. Erratum in: N Engl J Med 2000 Oct 19;343(16):1204.

13.

Endoscopic colorectal cancer screening: a cost-saving analysis.

Loeve F, Brown ML, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema JD.

J Natl Cancer Inst. 2000 Apr 5;92(7):557-63.

14.
15.

A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.

Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C.

BMJ. 1998 Aug 29;317(7158):559-65.

16.

Colorectal cancer screening: clinical guidelines and rationale.

Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ.

Gastroenterology. 1997 Feb;112(2):594-642. No abstract available. Erratum in: Gastroenterology 1997 Mar;112(3):1060. Gastroenterology 1998 Mar;114(3):625.

PMID:
9024315
17.

Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O.

Lancet. 1996 Nov 30;348(9040):1467-71.

PMID:
8942774
18.

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F.

N Engl J Med. 1993 May 13;328(19):1365-71. Erratum in: N Engl J Med 1993 Aug 26;329(9):672.

19.

Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study.

Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS.

Ann Intern Med. 1993 Jan 1;118(1):1-6.

PMID:
8416152
20.

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, et al.

N Engl J Med. 1993 Dec 30;329(27):1977-81.

Items per page

Supplemental Content

Support Center